Related Experiment Video

Updated: Dec 21, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.3K

Costs of Respiratory Syncytial Virus Hospitalizations in Colombia

Jefferson Antonio Buendía1, Diana Guerrero Patiño2

  • 1Department of Pharmacology and Toxicology, Research Group in Pharmacology and Toxicology (INFARTO), Centro de Información y Estudio de Medicamentos y Tóxicos (CIEMTO), Faculty of Medicine, Universidad de Antioquia, Carrera 51D #62-29, Medellín, Colombia. jefferson.buendia@gmail.com.

Pharmacoeconomics - Open
|May 18, 2020
PubMed

Insights

Respiratory syncytial virus (RSV) hospitalizations in Colombian infants incur substantial medical costs, largely due to inappropriate medication use. This highlights the economic burden and need for better prevention strategies.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Health Economics

Background:

  • Clinical guidelines for respiratory syncytial virus (RSV) management exist, yet medication and test overuse with limited evidence persists.
  • RSV infection poses a significant challenge in pediatric healthcare settings.

Purpose of the Study:

  • To evaluate the medical costs associated with bronchiolitis hospitalizations caused by RSV in infants under two years old in Colombia.
  • To understand the economic impact of RSV on the Colombian healthcare system.

Main Methods:

  • A prevalence-based cost-of-illness study was conducted from a societal perspective (2016-2017).
  • Cases were defined as laboratory-confirmed RSV infections requiring hospitalization.
  • Data on costs and resource utilization were collected directly from medical invoices and health records.

Main Results:

  • The study included 193 pediatric patients diagnosed with RSV.
  • Average hospital stay was 5.55 days, with room costs (31.5%), drugs (21.8%), and indirect costs (14.9%) being major cost drivers.
  • A high percentage of medications, including systemic antibiotics (96%), bronchodilators (90%), and corticosteroids (86%), were deemed inappropriate.

Conclusions:

  • RSV infection imposes a significant economic burden on the Colombian health system.
  • Comprehensive data on healthcare resource use and costs are crucial for developing cost-effectiveness models.
  • Findings can guide the development of targeted RSV prevention strategies.
Abstract

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.8K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.2K

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
906
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
369
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
695
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
656
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.8K